ROC curve analysis was used to define the optimal cut-off to determine the sensitivity and specificity of serum GDF15 for categorizing cirrhotic PBC patients versus non-cirrhotic PBC patients. This evidence concerns the gene GDF15 and primary biliary cholangitis.